Miphic

Miphic is a company that has developed the world's first mitochondrial drug discovery and precision medicine platform. They perform multiparametric mitochondrial screening for metabolic drug discovery, personalized medicine choice, and fundamental research on metabolism. Their technology uses an imaging-based approach to compare how mitochondria react to different drugs, metabolites, and stress conditions. Miphic also offers additional services such as deep data analysis and machine learning modelling for large-scale screening projects.